Yanover, C., Magen-Rimon, R., Voss, E. A., Swerdel, J., Sheahan, A., Hall, N., Park, J., Park, R. W., Lee, K. J., Shin, S. J., Seo, S. I., Lee, K.-J., Falconer, T., Haas, L., Nagy, P., Bowring, M. G., Cook, M., Miller, S., El-Hay, T., … Weisshof, R. (2024). Characteristics and Outcomes of Over a Million Patients with Inflammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data Resource. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08787-x

Wang, S., & Shen, B. (2025). Endoscopy for Altered Anatomy in Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America, 35(1), 103–120. https://doi.org/10.1016/j.giec.2024.04.004

Mårild, K., Söderling, J., Axelrad, J., Halfvarson, J., Forss, A., Michaëlsson, K., Olén, O., & Ludvigsson, J. F. (2024). A nationwide cohort study of inflammatory bowel disease, histological activity and fracture risk. Alimentary Pharmacology & Therapeutics, 60(11–12), 1549–1560. Portico. https://doi.org/10.1111/apt.18275

Gnanapandithan, K., Stuessel, L. G., Shen, B., Mourad, F. H., Peng, Z., Farraye, F. A., & Hashash, J. G. (2024). Pelvic Radiation Therapy Increases Risk of Pouch Failure in Patients with Inflammatory Bowel Disease and Ileal Pouch. Digestive Diseases and Sciences, 69(9), 3392–3401. https://doi.org/10.1007/s10620-024-08576-6

Sun, J., Yao, J., Olén, O., Halfvarson, J., Bergman, D., Ebrahimi, F., Rosengren, A., Sundström, J., & Ludvigsson, J. F. (2024). Risk of heart failure in inflammatory bowel disease: a Swedish population-based study. European Heart Journal, 45(28), 2493–2504. https://doi.org/10.1093/eurheartj/ehae338

Yang, Y., Ludvigsson, J. F., Olén, O., Sjölander, A., & Carrero, J. J. (2023). Estimated Glomerular Filtration Rate and the Risk of Inflammatory Bowel Disease in Adults: A Swedish Population-Based Study. Inflammatory Bowel Diseases, 30(5), 718–725. https://doi.org/10.1093/ibd/izac267

Mao, Z., Betti, M. J., Cedeno, M. A., Pedroza, L. A., Basaria, S., Liu, Q., Choi, J. M., & Markle, J. G. (2023). Clinical and cellular phenotypes resulting from a founder mutation in IL10RB. Clinical and Experimental Immunology, 216(2), 113–119. https://doi.org/10.1093/cei/uxad085

Xin, R. (2024). Inflammatory Gene Panel Guiding the Study of Genetics in Inflammatory Bowel Disease. Molecular Diagnosis & Therapy, 28(4), 389–401. https://doi.org/10.1007/s40291-024-00709-x

Ricciuto, A., Liu, K., El‐Matary, W., Amin, M., Amir, A. Z., Aumar, M., Auth, M., Di Guglielmo, M. D., Druve Tavares Fagundes, E., Rodrigues Ferreira, A., Furuya, K. N., Gupta, N., Guthery, S., Horslen, S. P., Jensen, K., Kamath, B. M., Kerkar, N., Koot, B. G. P., … Laborda, T. J. (2024). Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium. Alimentary Pharmacology & Therapeutics, 59(10), 1236–1247. Portico. https://doi.org/10.1111/apt.17936

Eriksson, C., Sun, J., Bryder, M., Bröms, G., Everhov, Å. H., Forss, A., Jernberg, T., Ludvigsson, J. F., & Olén, O. (2024). Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study. Alimentary Pharmacology & Therapeutics, 59(9), 1122–1133. Portico. https://doi.org/10.1111/apt.17932

Lee, K. E., Sizemore, J. A., Kim, G., Shen, B., & Sands, B. E. (2024). Impact of Biologics and Small-Molecule Agents on Postoperative Complications in IBD: A Systematic Review. Diseases of the Colon & Rectum, 67(S1), S11–S25. https://doi.org/10.1097/dcr.0000000000003222

Varma, S., Trudeau, S. J., Li, J., & Freedberg, D. E. (2023). Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series. Inflammatory Bowel Diseases, 30(1), 38–44. https://doi.org/10.1093/ibd/izad035

Yang, Y., Ludvigsson, J. F., Olén, O., Sjölander, A., & Carrero, J. J. (2023). Absolute and Relative Risks of Kidney and Urological Complications in Patients With Inflammatory Bowel Disease. American Journal of Gastroenterology, 119(1), 138–146. https://doi.org/10.14309/ajg.0000000000002473

Uchida, A. M., Garber, J. J., Pyne, A., Peterson, K., Roelstraete, B., Olén, O., Halfvarson, J., & Ludvigsson, J. F. (2023). Eosinophilic esophagitis is associated with increased risk of later inflammatory bowel disease in a nationwide Swedish population cohort. United European Gastroenterology Journal, 12(1), 34–43. Portico. https://doi.org/10.1002/ueg2.12493

Zubrzycka, I., Bogale, K., Stuart, A., Cesaire, M., Walter, V., Dalessio, S., Tinsley, A., Williams, E., Clarke, K., & Coates, M. D. (2023). Abdominal pain is associated with an increased risk of future healthcare resource utilization in inflammatory bowel disease. International Journal of Colorectal Disease, 38(1). https://doi.org/10.1007/s00384-023-04510-w

Chatila, W. K., Walch, H., Hechtman, J. F., Moyer, S. M., Sgambati, V., Faleck, D. M., Srivastava, A., Tang, L., Benhamida, J., Ismailgeci, D., Campos, C., Wu, F., Chang, Q., Vakiani, E., de Stanchina, E., Weiser, M. R., Widmar, M., Yantiss, R. K., Shah, M. A., … Yaeger, R. (2023). Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers. Nature Communications, 14(1). https://doi.org/10.1038/s41467-022-35592-9

Olén, O., Smedby, K. E., Erichsen, R., Pedersen, L., Halfvarson, J., Hallqvist-Everhov, Å., Bryder, N., Askling, J., Ekbom, A., Sachs, M. C., Sørensen, H. T., Ludvigsson, J. F., Olsson, M., Myrelid, P., Hjortswang, H., Bengtsson, J., Strid, H., Andersson, M., Jäghult, S., … Karling, P. (2023). Increasing Risk of Lymphoma Over Time in Crohn’s Disease but Not in Ulcerative Colitis: A Scandinavian Cohort Study. Clinical Gastroenterology and Hepatology, 21(12), 3132–3142. https://doi.org/10.1016/j.cgh.2023.04.001

Mårild, K., Söderling, J., Axelrad, J., Halfvarson, J., Forss, A., Olén, O., Ludvigsson, J. F., Olsson, M., Myrelid, P., Hjortswang, H., Bengtsson, J., Strid, H., Andersson, M., Jäghult, S., Eberhardson, M., Nordenvall, C., Björk, J., Rejler, M., Grip, O., … Karling, P. (2024). Histologic Activity in Inflammatory Bowel Disease and Risk of Serious Infections: A Nationwide Study. Clinical Gastroenterology and Hepatology, 22(4), 831–846. https://doi.org/10.1016/j.cgh.2023.10.013

Axelrad, J. E., Olén, O., Söderling, J., Roelstraete, B., Khalili, H., Song, M., Faye, A., Eberhardson, M., Halfvarson, J., & Ludvigsson, J. F. (2023). Inflammatory Bowel Disease and Risk of Colorectal Polyps: A Nationwide Population-Based Cohort Study From Sweden. Journal of Crohn’s and Colitis, 17(9), 1395–1409. https://doi.org/10.1093/ecco-jcc/jjad056

Sun, J., Roelstraete, B., Svennberg, E., Halfvarson, J., Sundström, J., Forss, A., Olén, O., & Ludvigsson, J. F. (2023). Long-term risk of arrhythmias in patients with inflammatory bowel disease: A population-based, sibling-controlled cohort study. PLOS Medicine, 20(10), e1004305. https://doi.org/10.1371/journal.pmed.1004305

Faye, A. S., Axelrad, J. E., Sun, J., Halfvarson, J., Söderling, J., Olén, O., & Ludvigsson, J. F. (2023). Atherosclerosis as a Risk Factor of Inflammatory Bowel Disease: A Population-Based Case-Control Study. American Journal of Gastroenterology, 119(2), 313–322. https://doi.org/10.14309/ajg.0000000000002502

Santiago, P., Coelho-Prabhu, N., Lennon, R., Rui, S., Rajauria, P., Friton, J., Raffals, L. E., Deepali, F., Daoud, N., Farraye, F. A., Tuck, J., Malik, T., Leleiko, N. S., Shapiro, J., Shah, S. A., Sands, B. E., & Ungaro, R. C. (2023). Baseline Clinical Factors Are Associated With Risk of Complications in Crohn’s Disease: Appraisal of the American Gastroenterological Association Clinical Care Pathway. American Journal of Gastroenterology, 119(1), 147–154. https://doi.org/10.14309/ajg.0000000000002498

Sun, J., Halfvarson, J., Appelros, P., Bergman, D., Ebrahimi, F., Roelstraete, B., Olén, O., & Ludvigsson, J. F. (2023). Long-term Risk of Stroke in Patients With Inflammatory Bowel Disease. Neurology, 101(6). https://doi.org/10.1212/wnl.0000000000207480

DiGiacomo, D. V., Roelstraete, B., Hammarström, L., Farmer, J. R., Khalili, H., & Ludvigsson, J. F. (2023). Predominant Antibody Deficiency and Risk of Microscopic Colitis: a Nationwide Case–Control Study in Sweden. Journal of Clinical Immunology, 43(6), 1426–1435. https://doi.org/10.1007/s10875-023-01499-3

D’Antongiovanni, V., Pellegrini, C., Fornai, M., Nemeth, Z. H., Haskó, G., & Antonioli, L. (2023). Pharmacological modulation of P2X4 in inflammatory bowel diseases: the way towards novel therapeutics? Journal of Drug Targeting, 31(7), 693–699. https://doi.org/10.1080/1061186x.2023.2235092

Gibson, M., Subedi, S., Barker, D. H., Masur, S., Mallette, M. M., Lingannan, A., Recinos Soto, A. A., Esharif, D., Maxwell, S. H., Riaz, M. S., Herzlinger, M. I., Shalon, L. B., Cerezo, C. S., Kasper, V. L., Ross, A. M., Leleiko, N. S., & Shapiro, J. M. (2023). Safety and Durability of Accelerated Infliximab Dosing Strategies in Pediatric IBD: A Single Center, Retrospective Study. Journal of Pediatric Gastroenterology & Nutrition, 77(2), 207–213. https://doi.org/10.1097/mpg.0000000000003794

Wang, K., Olén, O., Emilsson, L., Khalili, H., Halfvarson, J., Song, M., & Ludvigsson, J. F. (2023). Association of inflammatory bowel disease in first‐degree relatives with risk of colorectal cancer: A nationwide case‐control study in Sweden. International Journal of Cancer, 152(11), 2303–2313. Portico. https://doi.org/10.1002/ijc.34470

Hsu, N.-Y., Nayar, S., Gettler, K., Talware, S., Giri, M., Alter, I., Argmann, C., Sabic, K., Thin, T. H., Ko, H.-B. M., Werner, R., Tastad, C., Stappenbeck, T., Azabdaftari, A., Uhlig, H. H., Chuang, L.-S., & Cho, J. H. (2022). NOX1 is essential for TNFα-induced intestinal epithelial ROS secretion and inhibits M cell signatures. Gut, 72(4), 654–662. https://doi.org/10.1136/gutjnl-2021-326305

Carman, N., & Picoraro, J. A. (2023). Advances in Endoscopy for Pediatric Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America, 33(2), 447–461. https://doi.org/10.1016/j.giec.2022.10.002

Picoraro, J. A., Moore, H., & LeLeiko, N. S. (2023). Inflammatory Bowel Disease: An Update. Pediatrics In Review, 44(3), 139–152. https://doi.org/10.1542/pir.2022-005750

Sun, J., Fang, F., Olén, O., Song, M., Halfvarson, J., Roelstraete, B., Khalili, H., & Ludvigsson, J. F. (2023). Long-term risk of inflammatory bowel disease after endoscopic biopsy with normal mucosa: A population-based, sibling-controlled cohort study in Sweden. PLOS Medicine, 20(2), e1004185. https://doi.org/10.1371/journal.pmed.1004185

Liu, J. J., Abraham, B. P., Adamson, P., Barnes, E. L., Brister, K. A., Damas, O. M., Glover, S. C., Hooks, K., Ingram, A., Kaplan, G. G., Loftus, E. V., McGovern, D. P. B., Narain-Blackwell, M., Odufalu, F.-D., Quezada, S., Reeves, V., Shen, B., Stappenbeck, T. S., & Ward, L. (2022). The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases, 29(2), 297–307. https://doi.org/10.1093/ibd/izac124

Xu, Z., Chen, J. J., Mei, Q., Li, Y., & Xu, J. (2022). Expression of 5-hydroxytryptamine 7 receptor in intestinal mucosa correlates with the degree of intestinal inflammation in Crohn’s disease. BMC Gastroenterology, 22(1). https://doi.org/10.1186/s12876-022-02513-5

Liu, L., Khan, A., Sanchez-Rodriguez, E., Zanoni, F., Li, Y., Steers, N., Balderes, O., Zhang, J., Krithivasan, P., LeDesma, R. A., Fischman, C., Hebbring, S. J., Harley, J. B., Moncrieffe, H., Kottyan, L. C., Namjou-Khales, B., Walunas, T. L., Knevel, R., Raychaudhuri, S., … Kiryluk, K. (2022). Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-34456-6

Schiepatti, A., Sanders, D. S., Baiardi, P., Caio, G., Ciacci, C., Kaukinen, K., Lebwohl, B., Leffler, D., Malamut, G., Murray, J. A., Rostami, K., Rubio-Tapia, A., Volta, U., & Biagi, F. (2022). Nomenclature and diagnosis of seronegative coeliac disease and chronic non-coeliac enteropathies in adults: the Paris consensus. Gut, 71(11), 2218–2225. https://doi.org/10.1136/gutjnl-2021-326645

Shrestha, S., Brand, J. S., Järås, J., Schoultz, I., Montgomery, S., Askling, J., Ludvigsson, J. F., Olen, O., Halfvarson, J., Olsson, M., Hjortswang, H., Myrelid, P., Bengtsson, J., Strid, H., Andersson, M., Jäghult, S., Eberhardson, M., Nordenvall, C., … Karling, P. (2022). Association Between Inflammatory Bowel Disease and Spondyloarthritis: Findings from a Nationwide Study in Sweden. Journal of Crohn’s and Colitis, 16(10), 1540–1550. https://doi.org/10.1093/ecco-jcc/jjac065

Faye, A. S., Lee, K. E., Dodson, J., Chodosh, J., Hudesman, D., Remzi, F., Wright, J. D., Friedman, A. M., Shaukat, A., & Wen, T. (2022). Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis. Alimentary Pharmacology & Therapeutics, 56(7), 1157–1167. Portico. https://doi.org/10.1111/apt.17162

Kochar, B., Jylhävä, J., Söderling, J., Ritchie, C. S., Ludvigsson, J. F., Khalili, H., Olén, O., Olsson, M., Hjortswang, H., Myrelid, P., Bengtsson, J., Strid, H., Andersson, M., Jäghult, S., Eberhardson, M., Nordenvall, C., Björk, J., Fagerberg, U. L., Rejler, M., … Halfvarson, J. (2022). Prevalence and Implications of Frailty in Older Adults With Incident Inflammatory Bowel Diseases: A Nationwide Cohort Study. Clinical Gastroenterology and Hepatology, 20(10), 2358-2365.e11. https://doi.org/10.1016/j.cgh.2022.01.001

Householder, S., & Picoraro, J. A. (2022). Diagnosis and Classification of Fistula from Inflammatory Bowel Disease and Inflammatory Bowel Disease-Related Surgery. Gastrointestinal Endoscopy Clinics of North America, 32(4), 631–650. https://doi.org/10.1016/j.giec.2022.04.003

Everhov, Å. H., Erichsen, R., Järås, J., Pedersen, L., Halfvarson, J., Askling, J., Ekbom, A., Ludvigsson, J. F., Sørensen, H. T., & Olén, O. (2022). Colorectal cancer in elderly‐onset inflammatory bowel disease: a 1969–2017 Scandinavian register‐based cohort study. Alimentary Pharmacology & Therapeutics, 56(7), 1168–1182. Portico. https://doi.org/10.1111/apt.17175

Malick, A., & Shen, B. (2022). Endoscopic Treatment of Postoperative Bleeding, Bezoars, and Foreign Bodies. Gastrointestinal Endoscopy Clinics of North America, 32(4), 829–843. https://doi.org/10.1016/j.giec.2022.05.008

Shen, B. (2022). Principles, Preparation, Indications, Precaution, and Damage Control of Endoscopic Therapy in Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America, 32(4), 597–614. https://doi.org/10.1016/j.giec.2022.05.005

Everhov, Å. H., Ludvigsson, J. F., Järås, J., Erichsen, R., Pedersen, L., Halfvarson, J., Askling, J., Ekbom, A., Sørensen, H. T., & Olén, O. (2022). Colorectal Cancer in Childhood-onset Inflammatory Bowel Disease: A Scandinavian Register-based Cohort Study, 1969–2017. Journal of Pediatric Gastroenterology & Nutrition, 75(4), 480–484. https://doi.org/10.1097/mpg.0000000000003574

Pokala, A., & Shen, B. (2022). Endoscopic Treatment of Acute and Chronic Anastomotic Leaks from Inflammatory Bowel Disease Surgery. Gastrointestinal Endoscopy Clinics of North America, 32(4), 801–815. https://doi.org/10.1016/j.giec.2022.05.007

Mårild, K., Söderling, J., Lebwohl, B., Green, P. H. R., Pinto-Sanchez, M. I., Halfvarson, J., Roelstraete, B., Olén, O., & Ludvigsson, J. F. (2022). Association of Celiac Disease and Inflammatory Bowel Disease: A Nationwide Register-Based Cohort Study. American Journal of Gastroenterology, 117(9), 1471–1481. https://doi.org/10.14309/ajg.0000000000001834

Thunberg, J., Björkqvist, O., Hedin, C. R. H., Forss, A., Söderman, C., Bergemalm, D., Olén, O., Hjortswang, H., Strid, H., Ludvigsson, J. F., Eriksson, C., & Halfvarson, J. (2022). Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register. United European Gastroenterology Journal, 10(7), 631–639. Portico. https://doi.org/10.1002/ueg2.12275

Wen, T., Faye, A. S., Lee, K. E., Friedman, A. M., Wright, J. D., Lebwohl, B., & Colombel, J.-F. (2021). Risk of Postpartum Flare Hospitalizations in Patients with Inflammatory Bowel Disease Persists After Six Months. Digestive Diseases and Sciences, 67(9), 4278–4286. https://doi.org/10.1007/s10620-021-06999-z

Halfvarson, J., Ludvigsson, J. F., Bresso, F., Askling, J., Sachs, M. C., & Olén, O. (2022). Age determines the risk of familial inflammatory bowel disease—A nationwide study. Alimentary Pharmacology & Therapeutics, 56(3), 491–500. Portico. https://doi.org/10.1111/apt.16938

Lee, K. E., Lim, F., Colombel, J.-F., Hur, C., & Faye, A. S. (2021). Cost-effectiveness of Venous Thromboembolism Prophylaxis After Hospitalization in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 28(8), 1169–1176. https://doi.org/10.1093/ibd/izab246

Philippou, A., Sehgal, P., Ungaro, R. C., Wang, K., Bagiella, E., Dubinsky, M. C., & Keefer, L. (2021). High Levels of Psychological Resilience Are Associated With Decreased Anxiety in Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 28(6), 888–894. https://doi.org/10.1093/ibd/izab200